greyhound
kennel
owner
frequent
employ
multipl
vaccin
schedul
attempt
reduc
financi
loss
incur
result
infecti
diseas
order
determin
effect
multipl
vaccin
schedul
immun
system
race
greyhound
three
litter
greyhound
pup
rais
laboratori
condit
divid
two
group
subject
either
maximum
minimum
vaccin
schedul
blood
sampl
collect
biweekli
correspond
author
tel
fax
elsevi
scienc
bv
right
reserv
ssdi
gl
mcmillen
et
al
veterinari
immunolog
immunopatholog
month
begin
week
age
analyz
establish
baselin
valu
lymphat
system
greyhound
lymphocyt
transform
total
differenti
leukocyt
count
flow
cytometri
use
evalu
cellular
immun
humor
immun
evalu
use
serum
neutral
hemagglutin
inhibit
test
prolifer
peripher
blood
lymphocyt
respons
mitogen
concanavalin
con
higher
maximum
vaccin
group
frequenc
distribut
circul
igg
label
lymphocyt
higher
minimum
vaccin
group
signific
treatment
time
interact
igg
igm
label
cell
observ
interact
howev
signific
point
time
igg
label
cell
percentag
lymphocyt
express
surfac
igm
significantli
higher
minimum
vaccin
group
week
age
signific
differ
detect
humor
immun
maximum
minimum
group
litter
result
studi
indic
maximum
vaccin
schedul
appear
effect
immunosuppress
minimum
vaccin
schedul
viral
pathogen
particular
canin
parvoviru
cpv
canin
distemp
viru
cdv
caus
signific
financi
loss
greyhound
industri
order
circumv
loss
kennel
owner
attempt
elicit
earli
continu
immun
respons
administ
multipl
dose
vaccin
simultan
administr
cpv
cdv
vaccin
report
decreas
number
circul
lymphocyt
may
fact
produc
temporari
state
immunosuppress
kesel
neil
mastro
et
al
phillip
et
al
host
defens
system
tradit
divid
two
function
overlap
categori
humor
immun
system
cellular
immun
system
schultz
humor
immun
system
consist
blymphocyt
produc
immunoglobulin
helper
tlymphocyt
macrophag
killer
cell
effector
molecul
aspect
immun
system
evalu
use
antigenantibodi
interact
effector
cell
assay
evalu
complementmedi
activ
cellular
immun
system
consist
tlymphocyt
macrophag
cytokin
lymphocyt
prolifer
phenotyp
delay
type
hypersensit
commonli
use
evalu
cellular
immun
correl
antibodi
titer
protect
effect
immun
cpv
cdv
vaccin
indic
humor
immun
import
host
defens
pathogen
role
cellular
immun
particular
cpv
vaccin
receiv
less
attent
current
vaccin
protocol
greyhound
industri
administ
viral
antigen
frequent
younger
age
respons
pup
less
week
age
viral
antigen
report
lower
adult
dog
lymphocyt
prolifer
respons
mitogen
stimul
reach
adult
valu
week
month
age
bank
follow
studi
design
determin
effect
extens
vaccin
protocol
develop
immun
system
race
greyhound
wean
greyhound
pup
three
differ
dam
sire
randomli
divid
two
group
vaccin
histori
dam
unknown
except
one
dam
vaccin
multival
vaccin
da
lp
pv
prior
breed
group
hous
separ
pen
vaccin
either
maximum
minimum
vaccin
schedul
tabl
maximum
vaccin
schedul
model
current
vaccin
protocol
use
race
greyhound
industri
minimum
vaccin
schedul
close
resembl
recom
american
veterinari
medic
associ
avma
council
biolog
therapeut
agent
vaccin
administ
subcutan
except
rabi
intramuscular
parainfluenzabordetella
intranas
blood
sampl
collect
adult
week
prior
whelp
pup
everi
week
begin
week
age
end
month
age
blood
sampl
collect
untreat
preservativefre
heparin
edta
treat
tube
cpv
serum
antibodi
titer
assay
biweekli
use
hemagglutin
inhibit
hai
test
previous
describ
carmichael
et
al
hai
titer
record
reciproc
highest
serum
dilut
show
complet
inhibit
hemagglutin
cdv
serum
antibodi
titer
assay
biweekli
use
serumneutr
sn
test
previous
describ
appel
robson
sn
titer
record
reciproc
highest
serum
dilut
neutral
viral
cytopath
effect
vero
cell
atcc
ccl
canin
herpesviru
chv
canin
coronaviru
ccv
infecti
canin
hepat
ich
viru
serum
antibodi
level
assay
monthli
use
sn
test
primari
dog
kidney
swine
testicl
st
atcc
ccl
mandindarbi
canin
kidney
mdck
atcc
ccl
cell
respect
peripher
blood
mononuclear
cell
pbmc
isol
use
densiti
gradient
centrifug
fletcher
et
al
heparin
blood
dilut
l
phosphatebuff
salin
pb
ph
layer
onto
sigma
centrifug
x
g
min
leukocyt
layer
collect
wash
twice
media
gibco
laboratori
resuspend
concentr
x
cell
ml
contain
heat
inactiv
fetal
bovin
serum
fb
hyclon
laboratori
lglutamin
mm
penicillin
unit
ml
streptomycin
mg
ml
kanamycin
pg
ml
gentamicin
pg
mll
lymphocyt
respons
mitogen
stimul
assay
previous
describ
schultz
minor
modif
briefli
pbmc
dispens
ml
amount
cell
per
well
flat
bottom
tissu
cultur
plate
corn
glass
work
subject
follow
experiment
condit
cell
cell
pg
per
well
phytohemagglutininp
piia
sigma
cell
pg
per
well
concanavalin
con
sigma
cell
cpv
atcc
multipl
infect
moi
cell
cdv
onderstepoort
strain
kindli
donat
jame
baker
institut
anim
health
moi
test
conduct
replic
four
tritiat
thymidin
concentr
per
well
ad
h
incub
co
incub
cell
harvest
h
later
use
phdtm
cell
harvest
cambridg
technolog
inc
count
per
minut
cpm
determin
beckman
ls
scintil
counter
blastogen
respons
lymphocyt
express
stimul
index
sz
defin
ratio
experiment
control
cpm
leukocyt
differenti
count
perform
wrightstain
smear
made
edta
blood
sampl
total
white
blood
cell
wbc
red
blood
cell
rbc
count
determin
coulter
model
splu
iv
coulter
electron
inc
hialeah
fl
pbmc
dispens
ml
tube
concentr
x
cell
per
tube
wash
pb
ph
cell
suspens
analyz
onecolor
flow
microfluorometri
use
monoclon
antibodi
stain
conduct
either
direct
indirect
method
follow
fluorescein
isothiocyan
fitc
conjug
antibodi
pg
antidog
igm
fitc
conjug
bethyl
laboratori
inc
pg
antidog
igg
fitc
conjug
bethyl
laboratori
inc
pg
mous
antifelin
fitc
conjug
fisher
biotech
pug
biotinyl
mous
antifelin
fisher
biotech
follow
pug
avidinfitc
boehr
mannheim
biochem
pg
class
major
histocompat
complex
mhc
antigen
vmrd
follow
pg
goat
antimous
igm
fitc
bethyl
laboratori
inc
pg
class
ii
mhc
vmrd
follow
pg
goat
antimous
iggc
l
fitc
bethyl
laboratori
inc
laboratori
demonstr
antifelin
antibodi
fisher
biotech
select
bind
mutual
exclus
popul
canin
peripher
blood
lymphocyt
ds
mcvey
unpublish
data
proport
similar
canin
specif
antibodi
report
gebhard
carter
antibodi
incub
min
stain
cell
wash
twice
ml
pb
ph
fix
paraformaldehyd
resuspend
sheath
fluid
read
wavelength
nm
becton
dickinson
facscantm
flow
cytomet
equip
w
argon
laser
unstain
avidinfitc
stain
antimous
igmfitc
stain
antimous
iggfitc
stain
cell
serv
control
forward
light
scatter
gate
set
lymphocyt
fraction
exclud
dead
cell
erythrocyt
lymphocyt
analyz
test
filter
system
use
measur
light
emit
nm
detect
fitc
analysi
perform
use
lysi
version
program
percentag
posit
cell
express
percent
posit
stain
cell
marker
minu
control
analysi
conduct
use
mix
model
analysi
varianc
procglm
program
statist
analysi
system
signific
p
comparison
made
treatment
within
litter
within
treatment
time
two
dam
vaccin
prebreed
averag
antibodi
titer
cpv
cdv
dam
vaccin
prebreed
cpv
cdv
antibodi
titer
respect
matern
deriv
antibodi
level
cpv
nonprotect
hai
pollock
carmichael
pup
earli
week
age
pup
week
age
tabl
averag
matern
deriv
antibodi
level
cdv
less
week
age
tabl
although
antibodi
titer
vari
time
signific
differ
detect
maximum
minimum
vaccin
group
antibodi
respons
cpv
cdv
vaccin
averag
cpv
antibodi
titer
near
protect
valu
week
age
antibodi
titer
subsequ
declin
two
litter
week
age
increas
protect
level
litter
month
age
fig
averag
cdv
antibodi
titer
week
age
tabl
maximum
cdv
antibodi
titer
observ
week
age
fig
cellular
immun
lymphocyt
prolifer
respons
con
stimul
gener
higher
si
respons
pha
sz
stimul
tabl
lo
lo
lo
ioo
nd
nd
nd
litter
dam
vaccin
immedi
prior
breed
number
parenthes
number
pup
test
litter
n
litter
n
litter
n
nd
test
done
week
age
prolifer
respons
antigen
cpv
si
cdv
sz
lower
respons
mitogen
stimul
tabl
signific
differ
two
vaccin
group
respons
pha
cpv
cdv
signific
differ
detect
p
respons
con
stimul
tabl
signific
differ
detect
express
class
class
ii
antigen
major
histocompat
complex
percentag
label
cell
two
vaccin
group
tabl
signific
treatment
effect
detect
p
igg
p
label
cell
tabl
addit
treatment
time
interact
observ
p
igg
label
cell
maximum
vaccin
group
higher
week
age
follow
minimum
vaccin
group
equal
higher
week
age
fig
tabl
specif
point
time
howev
interact
signific
treatment
time
interact
observ
igm
label
cell
p
maximum
vaccin
group
higher
percentag
posit
cell
week
age
follow
minimum
vaccin
group
equal
higher
week
age
week
age
minimum
vaccin
group
significantli
higher
percentag
lymphocyt
express
surfac
igm
maximum
vaccin
group
pvalu
respect
fig
tabl
data
present
indic
signific
differ
occur
humor
immun
respons
race
greyhound
subject
multipl
vs
minim
vaccin
schedul
antibodi
level
cpv
cdv
increas
earlier
time
period
greyhound
vaccin
week
age
compar
vaccin
week
age
addit
antibodi
level
reach
higher
level
greyhound
vaccin
multipl
vaccin
schedul
fig
suggest
appar
increas
protect
diseas
greyhound
vaccin
earlier
age
frequent
matern
antibodi
level
canin
parvoviru
nonprotect
time
whelp
two
adult
greyhound
even
though
obtain
track
kennel
environ
exposur
natur
cpv
like
third
femal
vaccin
prebreed
achiev
cpv
antibodi
titer
time
whelp
reason
poor
antibodi
level
adult
greyhound
unknown
could
attribut
environment
stress
averag
antibodi
titer
cpv
vaccin
poor
experiment
group
puppi
achiev
protect
antibodi
titer
week
age
although
reason
poor
antibodi
respons
cpv
unknown
note
schedul
initi
use
kill
parvo
vaccin
recent
report
blyth
et
al
advoc
use
kill
parvo
vaccin
week
age
kennel
situat
state
modifi
live
parvo
vaccin
lower
immun
statu
pup
day
recent
work
laboratori
investig
use
modifi
live
parvo
vaccin
greyhound
pup
begin
week
age
vaccin
everi
week
record
higher
cpv
antibodi
titer
kill
vaccin
use
unpublish
data
modifi
live
vaccin
typic
give
better
immun
respons
kill
vaccin
virtu
abil
undergo
limit
replic
host
stimul
cellmedi
antibodymedi
immun
elli
sinc
kill
vaccin
replic
host
inher
less
effici
induc
cellmedi
immun
system
possibl
kill
parvo
vaccin
administr
young
greyhound
result
enough
seroconvers
inhibit
abil
modifi
live
vaccin
replic
consequ
lower
antibodi
titer
cpv
result
declin
cpv
antibodi
titer
observ
two
litter
week
age
similar
declin
cdv
antibodi
titer
postvaccin
report
greyhound
webster
cpv
cdv
vaccin
report
immunosuppress
caus
decreas
number
circul
lymphocyt
abil
respond
mitogen
povey
mastro
et
al
krakowka
et
al
phillip
et
al
anoth
studi
howev
found
evid
immunosuppress
result
cpv
vaccin
phillip
schultz
recent
studi
miyamoto
et
al
report
decreas
leukocyt
lymphocyt
count
day
post
vaccin
puppi
adult
dog
studi
also
demonstr
increas
blastogen
respons
lymphocyt
vaccin
puppi
chang
adult
dog
consequ
suppress
indic
lymphopenia
decreas
respons
mitogen
stimul
may
depend
upon
sampl
time
postvaccin
investig
conduct
order
examin
differ
immun
respons
tradit
vs
aggress
vaccin
protocol
determin
aggress
vaccin
benefici
term
immun
function
throughout
studi
leukocyt
lymphocyt
count
remain
within
normal
refer
rang
data
shown
abil
peripher
blood
lymphocyt
respond
normal
mitogen
diminish
result
multipl
vaccin
administr
maximum
vaccin
group
exhibit
greater
respons
stimul
con
minimum
vaccin
group
effect
could
due
frequent
stimul
immun
system
maximum
vaccin
schedul
result
prolifer
immatur
tlymphocyt
subpopul
miyamoto
et
al
suggest
vaccin
may
act
immunomodulatori
fashion
puppi
result
increas
blastogen
respons
maximum
vaccin
group
exhibit
greater
respons
minimum
vaccin
group
stimul
pha
con
shown
strict
tcell
mitogen
dog
pha
capabl
caus
tlymphocyt
blymphocyt
differenti
krakowka
ringler
immatur
tlymphocyt
compris
greater
percentag
peripher
blood
popul
maximum
vaccin
group
immatur
tlymphocyt
would
respons
con
pha
lymphocyt
phenotyp
perform
mani
year
human
mice
rel
reagent
exist
phenotyp
anim
speci
particular
dog
owe
lack
commerci
avail
specif
canin
reagent
crossreact
antifelin
marker
use
antibodi
bind
mutual
exclus
popul
canin
peripher
blood
lymphocyt
proport
similar
monoclon
describ
gebhard
carter
coexpress
approxim
thymocyt
beagl
pup
agreement
proport
doubl
posit
lymphocyt
express
thymu
speci
monoclon
defin
tompkin
et
al
antifelin
antibodi
addit
bind
canin
peripher
blood
granulocyt
immunoprecipit
reduc
peptid
rang
kda
compar
report
canin
specif
antibodi
gebhard
carter
report
normal
valu
lymphocyt
subpopul
adult
dog
cat
similar
tand
lymphocyt
dog
lymphocyt
cat
dean
et
al
gebhard
carter
age
antigen
load
environment
condit
howev
may
greatli
influenc
lymphocyt
subpopul
jole
et
al
multipl
vaccin
administr
significantli
alter
frequenc
distribut
igg
label
lymphocyt
signific
treatment
effect
treatment
time
interact
exist
label
lymphocyt
lymphocyt
express
surfac
igg
averag
weekli
mean
minimum
vaccin
group
higher
maximum
vaccin
group
week
age
complet
studi
fig
differ
howev
signific
one
point
time
least
squar
mean
compar
consequ
differ
treatment
appear
depend
week
sampl
time
post
vaccin
specif
treatment
signific
treatment
time
interact
observ
igm
express
cell
indic
minimum
vaccin
group
significantli
higher
percentag
peripher
blood
lymphocyt
express
surfac
igm
week
age
compar
maximum
vaccin
group
fig
could
result
differ
sampl
time
post
vaccin
two
treatment
group
minimum
vaccin
group
receiv
modifi
live
vaccin
week
prior
sampl
time
maximum
vaccin
group
receiv
kill
vaccin
week
age
modifi
live
vaccin
week
age
higher
percentag
igm
express
lymphocyt
may
reflect
seroconvers
minimum
vaccin
group
similar
prolifer
could
occur
maximum
vaccin
group
week
modifi
live
vaccin
due
differ
sampl
time
post
vaccin
respons
detect
addit
overal
signific
treatment
effect
detect
igm
express
lymphocyt
consequ
like
repres
defici
immun
respons
maximum
vaccin
group
administr
extens
vaccin
schedul
describ
common
practic
race
greyhound
industri
extens
vaccin
protocol
use
attempt
provid
earli
complet
protect
common
viral
pathogen
prevent
extens
financi
loss
due
diseas
outbreak
cost
support
extens
vaccin
protocol
greyhound
industri
one
counti
alon
kansa
estim
year
experiment
evid
present
report
indic
use
multipl
vaccin
protocol
race
greyhound
rais
laboratori
condit
increas
abil
humor
immun
system
respond
viral
antigen
although
practic
appear
detriment
immun
system
cost
vs
benefit
implement
extens
vaccin
schedul
question
import
note
howev
race
greyhound
kennel
situat
expos
environment
condit
present
laboratori
experi
describ
therefor
evalu
influenc
multipl
vaccin
schedul
immun
system
race
greyhound
rais
kennel
situat
expos
environment
stress
current
conduct
laboratori
